Anti-Cancer Drugs Journal Citation Rate 2026
0959-4973
eISSN 1473-5741
Lippincott Williams & Wilkins
GB
Q2 Quartile
About Anti-Cancer Drugs
Anti-Cancer Drugs (AD) is a peer-reviewed academic journal, published by Lippincott Williams & Wilkins in GB, catalogued under ISSN 0959-4973 (e-ISSN 1473-5741). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.73 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
Anti-Cancer Drugs Citation Rate 2026 — In Context
Anti-Cancer Drugs has a 2025 2-Year Citation Rate (OpenAlex) of 1.73, placing it in the Q2 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Anti-Cancer Drugs operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Anti-Cancer Drugs should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Anti-Cancer Drugs against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 0959-4973 |
|---|---|
| ISSN (Online) | 1473-5741 |
| Publisher | Lippincott Williams & Wilkins |
| Country | United Kingdom |
| APC / Cost | Inquire with Publisher |
| h-index | 114 |
| Total Works | 5,084 |
| Total Citations | 107,835 |
| 2-yr Mean Citedness | 1.95 (OpenAlex) |
In-depth profile & metrics
Anti-Cancer Drugs is published by Lippincott Williams & Wilkins and based in United Kingdom.
Editorially, Anti-Cancer Drugs concentrates on Cancer therapeutics and mechanisms, Cancer Treatment and Pharmacology and Colorectal Cancer Treatments and Studies.
Anti-Cancer Drugs is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
OpenAlex records 5,084 works that have together drawn 107,835 citations, giving the journal an h-index of 114; its most recent citation rate stands at 1.728; OpenAlex puts its two-year mean citedness at 1.95.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Anti-Cancer Drugs
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.728 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 120 | 169 |
| 2024 | 106 | 337 |
| 2023 | 85 | 448 |
| 2022 | 206 | 1,568 |
| 2021 | 239 | 2,340 |
| 2020 | 146 | 1,783 |
| 2019 | 140 | 2,009 |
| 2018 | 145 | 2,405 |
| 2017 | 118 | 2,738 |
| 2016 | 135 | 2,379 |
| 2015 | 135 | 2,789 |
| 2014 | 134 | 3,200 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where Anti-Cancer Drugs most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S158028025
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.